Kathleen Fujino, MD
Obstetrics/Gynecology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 6 carriers
- Offices
- 5
Offices
5 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Plans that list them
22 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fujino’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G80719 · Current
Licensed to practise in California · since 1995 · expires 2028-06-30 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$241,203 in 2024
Medicaid paid $241,203 for 4,369 billed services this clinician did in 2024, up to 78 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 463 | $239,232 |
| Return visit (30+ min) | 136 | $529 |
| Short return visit (20+ min) | 344 | $464 |
| FETAL NON-STRESS TEST | 54 | $339 |
| Short return visit | 139 | $271 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 12 | $113 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 12 | $112 |
| Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervision | 16 | $61 |
| Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result | 26 | $41 |
| URINE PREGNANCY TEST | 47 | $34 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 28 | $7 |
| Initial prenatal care visit (report at first prenatal encounter with health care professional providing obstetrical care. Report also date of visit and, in a separate field, the date of the last menstrual period [LMP]) (Prenatal) | 20 | $0 |
| 2024 | 4,369 | 22 | 78 | $241,203 |
| 2023 | 1,592 | 13 | 65 | $289,592 |
| 2022 | 1,562 | 13 | 61 | $246,156 |
| 2021 | 2,475 | 14 | 74 | $380,303 |
| 2020 | 1,289 | 6 | 67 | $263,897 |
| 2019 | 1,083 | 3 | 84 | $281,839 |
| 2018 | 1,023 | 7 | 69 | $282,977 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 567 | $286,347 |
| Short return visit (20+ min) | 388 | $1,677 |
| Return visit (30+ min) | 172 | $494 |
| FETAL NON-STRESS TEST | 55 | $318 |
| Short return visit | 125 | $240 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 33 | $215 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 12 | $126 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 12 | $125 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 39 | $34 |
| URINE PREGNANCY TEST | 46 | $17 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 37 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 54 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 492 | $242,275 |
| Return visit (30+ min) | 201 | $1,315 |
| Short return visit (20+ min) | 389 | $1,071 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 29 | $463 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 29 | $461 |
| FETAL NON-STRESS TEST | 40 | $245 |
| Short return visit | 111 | $191 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 15 | $80 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 39 | $35 |
| URINE PREGNANCY TEST | 36 | $21 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 32 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 81 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 784 | $376,965 |
| Return visit (30+ min) | 361 | $1,166 |
| Short return visit (20+ min) | 417 | $859 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 39 | $325 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 39 | $325 |
| Short return visit | 190 | $318 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 55 | $156 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 20 | $88 |
| URINE PREGNANCY TEST | 148 | $57 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 80 | $43 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 82 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 120 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 687 | $261,442 |
| Return visit (30+ min) | 185 | $1,225 |
| Short return visit (20+ min) | 340 | $989 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 15 | $169 |
| Short return visit | 49 | $59 |
| URINE PREGNANCY TEST | 13 | $13 |
2019
| Clinic visit/encounter, all-inclusive | 700 | $280,149 |
| Short return visit (20+ min) | 245 | $853 |
| Return visit (30+ min) | 138 | $837 |
2018
| Clinic visit/encounter, all-inclusive | 732 | $281,128 |
| Short return visit (20+ min) | 150 | $561 |
| Return visit (30+ min) | 63 | $517 |
| FETAL NON-STRESS TEST | 35 | $466 |
| Service | 14 | $303 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 17 | $2 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $0 |
Drugs they prescribed that Part D paid
$8,280
Pharmacies billed $8,280 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 48) in 2024. Too few prescriptions to compare fairly with other clinicians.
40 generic and fewer than 11 brand-name prescriptions · $8,280 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Medroxyprogesterone Acetate | 12 | $21 | $2 |
Year by year
| 2024 | 48 | 17 | 0% (0) | None | $8,280 |
| 2023 | 56 | 17 | 0% (0) | 23% | $8,833 |
| 2022 | 47 | 16 | None | None | $7,226 |
| 2021 | 40 | 12 | 0% (0) | 40% | $14,096 |
| 2020 | 67 | 19 | 0% (0) | 33% | $13,365 |
| 2019 | 50 | 17 | 0% (0) | 26% | $9,140 |
| 2018 | 51 | 18 | 0% (0) | 43% | $12,686 |
| 2017 | 41 | 15 | 0% (0) | 32% | $5,829 |
| 2016 | 41 | 13 | 0% (0) | 29% | $6,079 |
| 2015 | 28 | 13 | 0% (0) | None | $2,567 |
| 2014 | 39 | 15 | None | 31% | $5,254 |
| 2013 | 51 | 17 | None | 35% | $6,114 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Medroxyprogesterone Acetate | 15 | $58 | $4 |
2022: 1 drug
| Medroxyprogesterone Acetate | 17 | $51 | $3 |
2021: 1 drug
| Medroxyprogesterone Acetate | 13 | $31 | $2 |
2020: 2 drugs
| Premarin | 15 | $5,626 | $375 |
| Medroxyprogesterone Acetate | 12 | $25 | $2 |
2019: 1 drug
| Medroxyprogesterone Acetate | 14 | $54 | $4 |
Money from drug and device companies
$17 in 2025
| 2025 | 1 | 1 | None | $17 |
| 2023 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CooperSurgical | Paragard T 380a | $17 | 1 payment
|
See the published payment
| CooperSurgical | Meals · 2025-11-08 | Paragard T 380a | $17 |
See earlier years (2023)
2023: $20
| Baxter Healthcare | Perclot | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093778698
- Licence
- CA G80719California G80719: Current · expires 2028-06-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G807190
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-04-06
- NPI last updated
- 2007-09-12
This is when the NPI record was last certified, not a medical board exam.